The most probable number (MPN) bioburden test method can be a valuable tool for determining bioburden counts when the typical bioburden test methods are problematic on a particular product or when a ...
Dublin, May 06, 2026 (GLOBE NEWSWIRE)-- The "Bioburden Testing Market - Products, Types and Applications" report has been added to ResearchAndMarkets.com's offering. The global market for Bioburden ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results